Anti-ATG7 antibody [EP1759Y]
- KO Validated
- RabMAb
- Recombinant
- What is this?
5
(3 Reviews)
|
(86 Publications)
Rabbit Recombinant Monoclonal ATG7 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 86 publications.
View Alternative Names
APG7L, ATG7, Ubiquitin-like modifier-activating enzyme ATG7, ATG12-activating enzyme E1 ATG7, Autophagy-related protein 7, Ubiquitin-activating enzyme E1-like protein, APG7-like, hAGP7
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ATG7 antibody [EP1759Y] (AB52472)
Immunocytochemistry/Immunofluorescence analysis of HT-29 (human colorectal adenocarcinoma) cells labelling ATG7 with purified ab52472 at 1/500. Cells were fixed with 100% methanol. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (ab150077) at 1/1000 dilution was used as the secondary antibody. Nuclei couterstained with DAPI (blue).
Secondary Only Control : PBS was used instead of the primary antibody as the negative control.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ATG7 antibody [EP1759Y] (AB52472)
Immunocytochemistry/Immunofluorescence analysis of HeLa cells labelling ATG7 with purified ab52472 at 1/100. Cells were fixed with 4% Paraformaldehyde and permeabilised with 0.1% Triton X-100. ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. Cells were counter-stained with ab7291 anti-Tubulin (mouse mAb) followed by ab150120, AlexaFluor®594 goat anti-mouse secondary both at 1/1000. Nuclei were counterstained with DAPI (blue).
For negative control 1, rabbit primary antibody was used followed by anti-mouse secondary antibody (ab150120). For negative control 2, ab7291 (mouse primary antibody) was used followed by anti-rabbit secondary antibody (ab150077).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-ATG7 antibody [EP1759Y] (AB52472)
Intracellular Flow Cytometry analysis of HeLa cells labelling ATG7 (red) with purified ab52472 at dilution of 1/100. The secondary antibody used was goat anti rabbit IgG (FITC) at 1/500. Cells were fixed with 4% paraformaldehyde. Isotype control antibody was Rabbit monoclonal IgG (black). The blue line shows cells without incubation with primary antibody and secondary antibody.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ATG7 antibody [EP1759Y] (AB52472)
Immunohistochemical analysis of paraffin-embedded human cervical carcinoma sections labelling ATG7 with purified ab52472 at a dilution of 1/500. The secondary antibody used was ab97051, Goat Anti-Rabbit IgG H&L (HRP) at a dilution of 1/500. The sample was counterstained with hematoxylin. Antigen retrieval was performed using EDTA Buffer; pH 9.0. PBS was used instead of the primary antibody as the negative control and is shown in the inset.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-ATG7 antibody [EP1759Y] (AB52472)
Overlay histogram showing HEK293 cells stained with unpurified ab52472 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab52472, 1/50 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HEK293 cells fixed with 100% methanol (5 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.
- IP
Unknown
Immunoprecipitation - Anti-ATG7 antibody [EP1759Y] (AB52472)
ab52472 at 1/30 dilution immunoprecipitating ATG7 in HEK293 whole cell lysate observed at 70 KDa (lanes 1 and 2).
Lane 1 (input) : HEK293 whole cell lysate 10ug
Lane 2 (+) : ab52472 + HEK293 whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab52472 in HEK293 whole cell lysate
For western blotting, ab52472 was used followed by VeriBlot for IP Detection Reagent (HRP) (ab131366) for detection at a dilution of 1/10,000.
Blocking and Diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-ATG7 antibody [EP1759Y] (ab52472)
Predicted band size: 49 kDa,77 kDa
false
- WB
Lab
Western blot - Anti-ATG7 antibody [EP1759Y] (AB52472)
False colour image of Western blot : Anti-ATG7 antibody [EP1759Y] staining at 1/100000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab52472 was shown to bind specifically to ATG7. A band was observed at 75 kDa in wild-type HeLa cell lysates with no signal observed at this size in ATG7 knockout cell line ab283307 (knockout cell lysate ab287353). To generate this image, wild-type and ATG7 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-ATG7 antibody [EP1759Y] (ab52472) at 1/100000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
ATG7 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human ATG7 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-atg7-knockout-hela-cell-line-ab283307'>ab283307</a>)
Lane 3:
HepG2 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Predicted band size: 77 kDa
Observed band size: 75 kDa
false
- WB
Unknown
Western blot - Anti-ATG7 antibody [EP1759Y] (AB52472)
Blocking and Diluting buffer 5% NFDM/TBST
All lanes:
Western blot - Anti-ATG7 antibody [EP1759Y] (ab52472) at 1/100000 dilution
Lane 1:
HEK293 whole cell lysate at 20 µg
Lane 2:
HepG2 whole cell lysate at 20 µg
Lane 3:
Jurkat whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 77 kDa
Observed band size: 70 kDa
false
- WB
Unknown
Western blot - Anti-ATG7 antibody [EP1759Y] (AB52472)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : ATG7 knockout HAP1 cell lysate (20 μg)
Lane 3 : Jurkat cell lysate (20 μg)
Lane 4 : HepG2 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab52472 observed at 77 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab52472 was shown to specifically react with ATG7 when ATG7 knockout samples were used. Wild-type and ProteinX knockout samples were subjected to SDS-PAGE. ab52472 and ab8245 (loading control to Apg7) were both diluted 1/2000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-ATG7 antibody [EP1759Y] (ab52472)
Predicted band size: 77 kDa
false
- WB
Lab
Western blot - Anti-ATG7 antibody [EP1759Y] (AB52472)
Western blot : Anti-ATG7 antibody [EP1759Y] ab52472 staining at 1/2000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 78 kDa in Wild-type U-87 MG cell lysates with no signal observed at this size in ATG7 knockout U-87 MG cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-ATG7 antibody [EP1759Y] (ab52472) at 1/2000 dilution
Lane 1:
Wild-type U-87 MG at 20 µg
Lane 2:
ATG7 knockout U-87 MG at 20 µg
Lane 3:
THP-1 at 20 µg
Lane 4:
Jurkat at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 78 kDa
Observed band size: 78 kDa
false
- WB
CiteAb
Western blot - Anti-ATG7 antibody [EP1759Y] (AB52472)
Western Blotting using Anti-ATG7 antibody [EP1759Y], ab52472. Publication image from Rubinsztein, D. C. et al., 2016, Nat Commun, 26837467. Legend direct from paper.
Autophagy modulates Notch signalling pathway.(a) Representative western blot showing levels of Notch1 and its downstream effectors. Autophagy was inhibited in HEK cells by Smartpool siRNA (KD) for ATG7 or ATG16L1 or activated by pcDNA/Beclin-Flag transfection. Scr=scrambled siRNA. Actin is loading control. (b) Quantification of western blots for Notch1 and effectors, relative to actin, normalized for relevant control. *P<0.05 or **P<0.01 by paired t-test. n=3 in triplicates. Error bars=s.e.m. (c) Representative western blot showing effect of ATG7 Smartpool siRNA knockdown and ATG7-wt cDNA rescue on Notch1 levels. (d) Quantification of western blots for Notch1 and ATG7, relative to actin, normalized for relevant control. *P<0.05 or **P<0.01 by paired t-test. NS denotes not significant. n=4. Error bars=s.e.m. (e) Representative western blot showing the effect of ATG16L1 Smartpool siRNA knockdown and ATG16L1 mStr rescue on Notch1 levels. (f) Quantification of western blots for Notch1 and ATG16L1/ATG16L1 mStr, relative to actin, normalized for relevant control. *P<0.05 or **P<0.01 by paired t-test. n=3. Error bars=s.e.m. (g,h) HEK cells were transfected with control (scrambled) siRNA/ATG16L1 siRNA +Dll1 ligands (ATG16L1KD), or pcDNA/Beclin-Flag. Notch pathway activity was measured by firefly luciferase reporter assay with RBP-Jκ coupled reporter using Renilla luciferase with constitutive promoter as control. Ratio of sample to control is shown. *P<0.05 and **P<0.01. NS denotes not significant by unpaired t-test. n=3. Error bars=s.e.m. (i) Effect of autophagy on the nuclear translocation of NICD. Scale bar, 20 µm for images of the upper panel. Scale bar, 5 µm for all lower panel images. (j) HEK cells were treated with rapamycin/starved with HBSS, or transfected with pcDNA/Beclin-1. Magnifications of areas in white boxes are shown in lower images and with DAPI in lower panels. Scale bar, 10 µm for upper panels. Scale bar, 5 µm for bottom two rows.
false
Related conjugates and formulations (3)
-
Anti-ATG7 antibody [EP1759Y] - BSA and Azide free
-
578 PE
PE Anti-ATG7 antibody [EP1759Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-ATG7 antibody [EP1759Y]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ATG7 plays a significant role in autophagy a cellular degradation pathway critical for cell survival under stress. ATG7 contributes to the formation of autophagosomes by facilitating conjugation of ATG8 family proteins including LC3 to phosphatidylethanolamine. It acts within complexes that regulate cellular energy balance and stress responses ensuring cells maintain their function and integrity. Knockdown of ATG7 can impair autophagic flux highlighting its importance in maintaining cellular processes.
Pathways
ATG7 is a central player in the autophagy pathway influencing cellular metabolism and turnover. It interacts closely with ATG5 and ATG12 in this pathway to form a conjugation system essential for autophagosome elongation. Additionally ATG7 is involved in the mTOR signaling pathway which regulates nutrient sensing and cellular growth. Interaction with proteins like mTOR allows ATG7 to integrate signals from nutrient availability and stress responses finely tuning the autophagy process.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (86)
Recent publications for all applications. Explore the full list and refine your search
Current medical science 45:1244-1253 PubMed41060356
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC endocrine disorders 25:173 PubMed40660152
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:112052 PubMed40463965
2025
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy reports 3:2392450 PubMed40395522
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:15572 PubMed40320451
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:81 PubMed39922805
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC musculoskeletal disorders 25:665 PubMed39182017
2024
Applications
Unspecified application
Species
Unspecified reactive species
Tropical medicine and infectious disease 9: PubMed38393131
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 30:9 PubMed38216914
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:108446 PubMed38034359
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com